Advertisement
Generic competition not a cure-all for high drug prices

Generic competition not a cure-all for high drug prices

By Alex Kacik  |  June 12, 2018

Although more generic drugs are coming through the pipeline, generic competition won't affect 46% of the estimated sales revenue of the top 100 drugs through 2023, according to a new report.

Senate committee to advance Creates Act this week

Senate committee to advance Creates Act this week

By Susannah Luthi  |  June 05, 2018

The Senate is clearing the way this week for a bipartisan bill supported by insurers and provider groups aimed at easing generic drugs' entry into the market, although the legislation's future in the House and Senate is unclear.

Health system-led drug company garners strong provider support

Health system-led drug company garners strong provider support

By Alex Kacik  |  May 24, 2018

Eighty percent of nearly 750 providers, payers and pharmaceutical companies polled said they are optimistic that the new health system-led generic-drug company will change the status quo, and 90% said they would buy drugs from it, according to a new survey.

Providers' solution for high drug prices: Make them ourselves

Providers' solution for high drug prices: Make them ourselves

By Alex Kacik and Tara Bannow  |  January 20, 2018

The new health system-led generic-drug company sent a shockwave through the healthcare industry, but experts warned that it would take plenty of time and capital to ultimately lower drug prices and mitigate shortages.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print